Anthony Chong
About Anthony Chong
Anthony Chong serves as the Senior Director of Process Development at Nektar Therapeutics, a position he has held since 2005. He has extensive experience in the pharmaceutical industry, having previously worked at Johnson Matthey Pharma Services, Roche Pharmaceuticals, and Stanford University.
Current Role at Nektar Therapeutics
Anthony Chong serves as the Senior Director of Process Development at Nektar Therapeutics. He has held this position since 2005, contributing to the company's development of innovative therapeutics. His role involves overseeing the process development strategies that are crucial for the advancement of Nektar's product pipeline.
Previous Experience at Johnson Matthey Pharma Services
Before joining Nektar Therapeutics, Anthony Chong worked at Johnson Matthey Pharma Services as the Director of Process Development & Manufacturing from 2001 to 2005. During his four years in this role, he was responsible for leading process development initiatives and manufacturing operations within the organization.
Background in Pharmaceuticals
Anthony Chong has extensive experience in the pharmaceutical industry. He worked at Roche Pharmaceuticals / Syntex Pharmaceuticals as the Director of Process Development from 1977 to 1995 for 18 years. He also held a director position at Johnson Matthey Pharma Services (Pharm-Eco) from 1995 to 1998, further solidifying his expertise in process development.
Education and Expertise
Anthony Chong earned his PhD in Organic Chemistry from the Massachusetts Institute of Technology, where he studied from 1973 to 1976. He also holds an AB in Chemistry from Cornell University, where he studied from 1971 to 1973. His educational background provides a strong foundation for his work in process development within the pharmaceutical sector.
Postdoctoral Fellowship at Stanford University
Anthony Chong completed a postdoctoral fellowship at Stanford University from 1976 to 1977. This experience contributed to his research skills and knowledge in the field of chemistry, which he has applied throughout his career in various roles within the pharmaceutical industry.